Investor Relations


Innophos is a global specialty ingredients provider with:

• strong cash delivery

• an attractive EBITDA profile, and

• $725m of revenue in 2016.

We provide specialty ingredients that deliver far-reaching, versatile benefits for the Food, Health, Nutrition (FHN) and select Industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphates, minerals, botanicals, proteins and other nutrition ingredients to help our customers make their food and beverages tastier and more nutritious, their vitamins and supplements healthier and more readily available to the body, and their industrial applications more durable and economic.

We have a strong, clearly defined vision for the future called Vision 2022 which establishes our ambitions to grow Innophos to be a $1.25 billion company with an attractive 20% Adjusted EBITDA margin by 2022. Vision 2022 focuses on more deeply aligning Innophos with consumer mega trends such as energized ageing, health and wellness, and clean eating and becoming a clear partner of choice for our customers by offering a broader set of innovative vital ingredient solutions for FHN markets while retaining a select, added value business in IS. We are steadfastly focused on executing against our three strategic pillars of operational excellence, commercial excellence and strategic growth to deliver on our Vision 2022 goals.

Innophos Key Facts:

• Annual revenues: $725 million (FY 2016)
• Total assets: $643 million (FY 2016)
• Nasdaq symbol: IPHS
• Employs approximately 1,400 people worldwide
• Acquired Novel Ingredients in August 2017
• Innophos IPO date: November 2, 2006
• Corporate headquarters: Cranbury, New Jersey USA
• Chairman, Chief Executive Officer and President: Kim Ann Mink, Ph.D

Stock Information

Quotes delayed at least 20 minutes. Information provided by eSignal.


Disclaimer

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

Innophos Holdings, Inc. (collectively with its subsidiaries and affiliated companies, "IPHS") has no control over the External Site, any data or other content contained therein or any additional linked websites. The link to the External Site is provided for convenience purposes only.

By clicking "Accept" you acknowledge and agree that neither IPHS nor third party provider Virtua Research, Inc. ("Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever, for the content, the data or the technical operation of the External Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against IPHS and Virtua and further acknowledge and agree that in no event shall IPHS or Virtua, their respective officers, employees, directors or agents be liable for any (i) direct, indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of, or related to, use of the External Site or this Disclaimer.

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out herein shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental or material breach or breach of a fundamental or material term), tort (including, without limitation, negligence and gross negligence), strict liability or any other legal or equitable theory, and even if IPHS and Virtua are advised of the possibility of the loss, damage, claim or liability. All claims under the foregoing causes and theories of action are released and waived by entering the External Site. The waiver and release specifically include, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

Information presented in the External Site is intended to be dated to the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards and procedures. IPHS and Virtua disclaim any duty or responsibility to monitor the External Site for such changes or to update the External Site following their occurrence.

If, in any jurisdiction, any part of this Disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this Disclaimer shall be restricted or eliminated to the minimum extent, and the remaining portions of this Disclaimer shall otherwise remain in full force and effect.

Non-GAAP Information

In addition to disclosing results determined in accordance with generally accepted accounting principles ("GAAP,") IPHS may also disclose certain non-GAAP and pro forma non-GAAP results of operations, including certain ratios, operational and miscellaneous data, as well as net income, diluted earnings per share, operating expenses, and operating income that make certain adjustments or exclude certain charges and gains that are outlined in the schedules included in this website. IPHS Management believes that this non-GAAP and pro forma non-GAAP information provides investors with additional information to assess IPHS operating performance by making certain adjustments or excluding costs or gains and assists investors in comparing our operating performance to prior periods. IPHS Management uses this non-GAAP and pro forma non-GAAP information, along with GAAP information, in evaluating its historical operating performance.

The non-GAAP information is not prepared in accordance with GAAP and may not be comparable to non-GAAP information used by other companies. The non-GAAP information should not be viewed as a substitute for, or superior to, other data prepared in accordance with GAAP.

Accept | Decline